1. Locoregional cancer treatment with magnetic drug targeting;Alexiou;Cancer Research,2000
2. Physiological aspects in magnetic drug-targeting;Lubbe;Journal of Magnetism and Magnetic Materials,1999
3. A.S. Lubbe, C. Bergemann, H. Riess, F. Schriever, P. Reichardt, K. Possinger, M. Matthias, B. Dorken, F. Herrmann, R. Gurtler, P. Hohenberger, N. Haas, R. Sohr, B. Sander, A.-J. Lemke, D. Ohlendorf, W. Huhnt, D. Huhn, Clinical experiences with magnetic drug targeting: a phase I study with 4’-Epidoxorubicin in 14 patients with advanced solid tumors, 56 (1996) 4686–4693.
4. A.S. Lubbe, C. Bergemann, W. Huhnt, T. Fricke, H. Riess, J.W. Brock, D. Huhn, Preclinical experiences with magnetic drug targeting: tolerance and efficacy, 56 (1996) 4694–4701.
5. Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumor agents;Widder;Advances in Pharmacology and Chemotherapy,1979